---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-291662"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2023-12-08T23:59:59+00:00"
generated_at: "2026-06-07T15:27:47.146241+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# EyePoint closes upsized $230M public offering for wet AMD Phase 3 trials

## Summary
- Closed upsized public offering of 13,529,411 shares at $17.00/share, raising ~$230M gross.
- Underwriters fully exercised option for 1,764,705 additional shares.
- Net proceeds to fund EYP-1901 wet AMD Phase 3 pivotal trials and early pipeline.
- Joint book-runners: J.P. Morgan, TD Cowen, Guggenheim; Cantor as additional book-runner.
- Offerings were upsized from $175M initial to $200M priced, then $230M at close.

## SEC filing metadata
- accession: 0001193125-23-291662
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2023-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000119312523291662/0001193125-23-291662-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000119312523291662/d613658d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-291662
- JSON: https://secwatch.observer/filing/0001193125-23-291662.json
- Plain text: https://secwatch.observer/filing/0001193125-23-291662.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.